Detecting familial defective apolipoprotein B-100: Three molecular scanning methods compared

Clinical Chemistry

Volumn 43, Issue 9, 1997, Pages 1630-1634

  Henderson, Bryony G ^a   Wenham, Philip R ^a   Peter Ashby, J ^a   Blundell, Gillian ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100;

ARTICLE; CHOLESTEROL BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENE MUTATION; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY;

EID: 0030821933     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.9.1630     Document Type: Article

References (28)

1. Innerarity TL, Mahley RW, Weisgraber KH, Bersot TP, Krauss RM, Vega GL. Familial defective apolipoprotein B-100: a mutation of apolipqprotein B that causes hypercholesterolaemia. J Lipid Res 1990;31:1337-49.
2. Myant NB. Familial defective apolipoprotein B-100: including some comparisons with familial hypercholesterolaemia [Review]. Atherosclerosis 1993:104:1-18.
3. Tybjærg-Hansen A, Humphries SE. Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolaemia and premature coronary artery disease. Atherosclerosis 1992;96: 91-107.
4. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986;232:34-47.
5. Soria LF, Ludwig EH, Clarke HRG, Vega GL, Grundy SM, McCarthy BJ. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc NatI Acad Sci U S A 1989;86:587-91.
6. Pullinger CR, Hennessy LK, Chatterton LK, Liu W, Love JA, Mendel CM. Familial ligand-defective apolipoprotein B: identification of a new mutation that decreases LDL receptor binding affinity. J Clin Invest 1995;95:1225-34.
7. Gaffney D, Reid JM, Cameron IM, Vass K, Caslake M, Shepherd J, Packard CJ. Independent mutations at codon 3500 of the apolipoprotein B gene are associated with hyperlipidaemia. Arterioscler Thromb Vase Biol 1995;15:1025-9.
8. Tybjærg-Hansen A, Gallagher J, Vincent J, Houlston RS, Talmud P, Dunning AM. Familial defective apolipoprotein B-100: detection in the United Kingdom and Scandinavia, and clinical characteristics of ten cases. Atherosclerosis 1990:80:235-42.
9. Hansen PS, Rüdiger N, Tybjærg-Hansen A, Færgeman O, Gregersen N. Detection of the apo B-3500 mutation (glutamine for arginine) by gene amplification and cleavage with Mspl. J Lipid Res 1991:32:1229-33.
10. Wenham PR, Newton CR, Houlston RS, Price WH. Rapid diagnosis of familial defective apolipoprotein B-100 by amplification refractory mutation system. Clin Chem 1991;37:1983-7.
11. Motti C, Funke H, Rust S, Dergunove A, Assmann G. Using mutagenic polymerase chain reaction primers to detect carriers of familial defective apolipoprotein B-100. Clin Chem 1991; 7:1762-6.
12. White MB, Carvalho M, Derse D, O'Brien SJ, Dean M. Detecting single base substitutions as heteroduplex polymorphisms. Genomics 1992;12:301-6.
13. Keen J, Lester D, Inglehearn C, Curtis A, Bhattacharya S. Rapid detection of single base mismatches as heteroduplexes on Hydrolink gels. Trends Genet 1991;7:5.
14. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A 1989;86:2733-70.
15. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the poiymerase chain reaction. Genomics 1989;5:874-9.
16. Myers RM, Lumelsky N, Lerman LS, Maniatis T. Detection of single base substitutions in total genomic DNA. Nature 1985; 313:495-8.
17. Wenham PR, Bloomfield P, Blundell G, Penney MD, Rae PWH, Walker SW. Familial defective apolipoprotein B-100: a study of patients from lipid clinics in Scotland and Wales. Ann Clin Biochem 1996:33:443-50.
18. Miller SA, Dykes DD, Polesky HF. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988:16:1215.
19. Kotze MJ, Langenhoven E, Peelers AV, Theart L, Oosthuizen CJJ. Detection of two point mutations causing familial defective apolipoprotein B-100 by heteroduplex analysis. Mol Cell Prob 1994;8: 513-8.
20. Nissen H, Hansen PS, Feergeman O, Hørder M. Mutation screening of the codon 3500 region of the apolipoprotein B gene by denaturing gradient gel electrophoresis. Clin Chem 1995;41: 419-23.
21. Glavac D, Dean M. Applications of heteroduplex analysis for mutation detection in disease genes. Hum Mutat 1995;6:281-7.
22. Wenham PR, Henderson BG, Penney MD, Ashby JP, Rae PWH, Walker SW. Familial ligand-defective apolipoprotein B-100: detection, biochemical features and haplotype analysis of the R3531C mutation in the UK. Atherosclerosis 1997:129:185-92.
23. Humphries SE, Gudnason V, Whittall R, Day INM. Single-strand conformation polymorphism analysis with high throughput modifications, and its use in mutation detection in familial hypercholesterolemia. Clin Chem 1997:43:427-35.
24. Jensen HK, Jensen LG, Hansen PS, Færgeman O, Gregersen N. High sensitivity of the single-strand conformation polymorphism method for detecting sequence variations in the low-density lipoprotein receptor gene validated by DNA sequencing. Clin Chem 1996:42:1140-6.
25. Hayashi K, Yandell DW. How sensitive is PCR-SSCP? Hum Mutat 1993:2:338-46.
26. März W, Baumstark MW, Scharnagl H, Ruzicka V, Buxbaum S, Herwig J, et al. Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patient with familial defective apolipoprotein B-100 results from heterozygous interaction of LDL subfractions with the LDL receptor. J Clin Invest 1993:92:2922-33.
27. Funke H, Rust S, Seedorf U, Brennhausen B, Chirazi A, Motti C, Assmann G. Homozygosity for familial defective apolipoprotein B-100 (FDB) is associated with lower plasma cholesterol concentration than homozygosity for familial hypercholesterolaemia (FH) [Abstract]. Circ Suppl 1992:86:1-691.
28. Fodde R, Losekoot M. Mutation detection by denaturing gradient gel electrophoresis. Hum Mutat 1994;3:83-94.